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Synthetic HEL peptides used in the present study. The HEL amino acid sequence is shown by the single letter code . In peptides 107-129, 110-129, and 112-129 the cysteine at position 127 has been substituted with alanine to prevent formation of a disulfide bridge with the cysteine at position 115.
51-66, 107-129, 110-129, and 112-129 (Fig. 2 ). In addition, cells from C3H mice responded to peptide [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Thus, at least three immunodominant T cell epitopes could be identified by using these peptides . Since T cell proliferative responses are restricted by class II MHC molecules (20, 21) , the finding that both C311 and B10.A(4R) mice respond to sequences 51-61 and 112-129 indicates that these peptides are recognized in association with the class II molecule shared by these strains, that is, I-A'. In contrast, the T cell determinant included in the sequence 1-18 is recognized in association with I-E' molecules, since it restimulated HEL-primed T cells from C3H mice, but not those from B10.A(4R) mice . All the other peptides tested failed to restimulate HEL-primed T cells.
Interaction ofHEL Peptides with I-A' and I-E* Molecules. To investigate the interaction of HEL peptides with class II molecules, we determined the ability of these peptides to compete for presentation with antigenic peptides to T cell hybridomas . Previous work has demonstrated that the competition of peptides for antigen presentation correlates well with their capability to bind to purified la molecules (4, 22) . In the competition assays we used glutaraldehyde-fixed LK 35.2 cells (expressing both I-Ak and I-Ek molecules) as APC, and two pairs of T cell hybridomas, restricted by either I-Ak or I-Ek, each specific for a different HEL peptide (Table I) . Three of these hybridomas recognize immunodominant peptides (we have isolated several independent hybrids with these specificities), whereas the peptide-MHC specificity expressed by hybridoma 2H6 .4 is rather rare in our hybridoma collection . Competition was assessed as a decrease in IL-2 production by T cell hybridomas in response to antigen and APC. A typical experiment is shown in Fig. 3 where the response of hybridoma 2C8.4 to peptide 110-129 was used as a read-out system to evaluate the capacity of all nonstimulatory HEL peptides to inhibit antigen pre- sentation. Strong competition is exerted by peptides 46-61, 51-61, and 51-66, intermediate competition by peptides 25-43, 31-43, and 74-86, and weak competition by peptides 101-116 and 105-120. The other peptides did not exhibit discernible competition in the concentration range used (up to 200 gM). The compilation of data from four to six experiments for each of the four hybridomas is presented in Table  II . A very good correlation was found between the competition values obtained for each pair of hybridomas restricted by either I-Ak or I-Ek, irrespective of their peptide specificity. Based on these results, several HEL peptides appear to interact with I-A' (using the shortest sequences of overlapping peptides in the set examined): In terms of competition for I-Ek molecules, 1-18 was found to be the most efficient peptide. This was expected, because the I-Ek-restricted component of anti-HEL response was also directed against this sequence (see in Fig. 2 ) . The T cell determinant appears to map in the NH2-terminal region of sequence 1-18, since the interaction of peptide 8-29 with I-Ek molecules is weaker than that of 1-18 ; furthermore, no response can be observed to peptide 8-29 after HEL priming, and hybridoma 1138 .1 also fails to recognize peptide 8-29 . In addition to 1-18, the following peptides were found to interact, rather weakly, with the I-Ek molecule : 25-43 (but not 31-43), 51-66 and, as for the I-Ak molecule, all the COOH-terminal HEL peptides tested in the region 101-129 (Table II) .
Immunogenicity ofNonimmunodominant HEL Peptides . So far the results have demonstrated that several of the HEL peptides, although capable of binding to class II molecules, cannot restimulate a response of HEL-primed T cells. We therefore determined the immunogenicity of these peptides by injecting them into C3H and B10.A(4R) mice. The control experiment in Fig. 4 confirms that the dominant peptide 1-18 is, as predicted (see Fig. 2 ), co-recognized only with I-Ek molecules, since it induces a proliferative T cell response in C3H but not in B10.A(4R) mice . Formal evidence for the restriction by I-El molecules of the T cell response to peptide 1-18 was obtained by the inhibition of cell proliferation by anti-Ia mAbs (data not shown) . An interesting situation is represented by the nondominant peptide (25- than in B10 .A(4R) mice. This finding indicates that peptide 25-43 is recognized by T cells preferentially in association with I-E' molecules, probably due to a low precursor frequency of I-A'-restricted clones specific for this peptide. The T cells induced by peptides 1-18 and 25-43 can be restimulated with HEL, which indicates that the antigenic determinants in these peptides become available upon processing of HEL. Conversely, the priming with peptide 94-110 induced T cells responding to the peptide but not to HEL, which indicates that this peptide is not generated (or destroyed) during processing . The same applies to T cells induced by peptide 74-86, that is, they can be restimulated with the peptide but not with HEL (Fig .  5) . As expected, the immunodominant peptide 1-18 induces a higher peptidedependent proliferative response than the nondominant peptides 25-43 and 94-110 .
In conclusion, two of the three nonimmunodominant peptides tested are not generated during processing, and therefore, cannot induce T cells upon priming with HEL. However, the third nondominant peptide (peptide 25-43) is available after processing, and thus, the nonresponsiveness to this peptide after priming with HEL must arise by a different mechanism.
In Vivo Competition between HEL Pe;6tidesforInteraction with Class IIMolecules. Since all HEL peptides tested were found to be immunogenic irrespective of whether they were immunodominant or not, we have examined the possibility that in vivo competition between different peptides for presentation by class II molecules may account for immunodominance. Previous studies have demonstrated that competition between self and non-self peptides for binding to class II molecules can occur in vivo (23) . To test the in vivo competition for I-A' molecules, we immunized B10.A(4R) mice with peptides 51-66, 74-86, 110-129, or with an equimolar amount of peptides 51-66 and 74-86 or 51-66 and 110-129. The results in Fig. 5 demonstrate that a vigorous antipeptide response is induced when each peptide is injected separately into mice . However, when the immunodominant peptide 51-66 is injected together with an equimolar dose of peptide 74-86, the proliferative T cell response to the latter is drastically reduced, whereas the response to 51-66 is affected only marginally. In contrast, injection of the two immunodominant peptides 51-66 and 110-129 together does not result in an appreciable competition in vivo. Surprisingly the response to 51-66 is even increased. Thus, immunodominant peptides can effectively compete with a nondominant one for induction of a response in vivo. It should be pointed out, however, that the nondominant peptide 74-86 tested in this experiment is not available after processing (Fig . 5 , and reference 24), and therefore, the latter fact rather than competition is the cause for nonresponsiveness to this peptide after priming with HEL. To investigate whether competition between HEL peptides in vivo is a physiologically relevant process, we chose a situation in which two peptides, one immunodominant and the other not, were both available after processing of HEL. Peptides 1-18 and 25-43 exemplify this situation since both interact with I-E' molecules, both induce a T cell response to themselves and to HEL, but only 1-18 is immunodominant . We therefore injected these peptides either separately or mixed in equimolar ratio into C3H mice . The results in In vivo competition between HEL peptides for interaction with I-Ak molecules. B10.A(4R) mice were immunized as in Fig. 2 In vivo competition between HEL peptides for interaction with I-Ek molecules. C3H mice were immunized as in Fig. 2 
Discussion
A peptide derived from a protein molecule is considered immunodominant when it restimulates a proliferative response ofT cells primed with the whole protein (25) . To determine the mechanisms underlying immunodominance, we have analyzed the proliferative T cell response elicited by a panel of synthetic HEL peptides in lymph node cells from HEL-primed mice . Three immunodominant T cell epitopes have been identified, in HEL sequences 1-18, 51-61, and 112-129. Epitopes 51-61 and 112-129 are recognized by T cells in association with I-A' molecules, whereas the epitope in HEL sequence 1-18 is recognized in association with I-Ek molecules. The epitope in sequence 51-61 had also been identified by Allen et al. (26) . Several other HEL peptides are not immunodominant, although they are capable of interacting with I-Ak or I-E' molecules or with both. At least two of them, 74-86 and 94-110, are not available after processing of HEL. Hence, immunization with HEL does not induce responses against these peptides, and conversely, T cells induced by these peptides do not react to HEL.
Most interesting is the case of peptide 25-43 . This peptide is not dominant, although it induces a response that can be recalled by HEL, which indicates that the epitope is available after antigen processing . The reason for the lack of dominance is twofold. First, the peptide, although it binds to I-Ak slightly better than to I-Ek molecules, induces only a marginal I-Ak-restricted response. A similar case has re-cently been noted by Guillet et al . (27) . This failure could result from a low frequency of the relevant clones in the T cell repertoire or the T cells induced may have a poor capacity to proliferate . Second, the precursor of I-E'-restricted T cells specific for peptide [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] are not activated because of in vivo competition by the response to the dominant peptide 1-18 . Since peptide 1-18 binds to I-El molecules better than peptide 25-43, the former is likely to inhibit binding of the latter to the presenting molecule . The two mechanisms together render the response to peptide 25-43 cryptic in H-2k Mice .
The results also demonstrate that the simultaneous presence of two immunodominant T cell epitopes, such as those in peptides 51-66 and 110-129 both interacting with I-Ak molecules, does not result in competition when peptides are injected together at equimolar concentrations . Similarly, no competition was observed when the mouse lysozyme peptide 46-62 was injected together with peptide 112-129 in B10.A(4R) mice, whereas a clear dose-dependent competition was achieved by increasing the amount of mouse lysozyme peptide 46-62 injected (23) . Such a coexistence is anticipated between peptides that bind with relatively high affinity to the presenting molecule, and thus, have both the chance to occupy a number of binding sites sufficient for T cell activation . However, we have observed an additional unexpected synergism between these peptides, in that the presence of peptide 110-129 enhanced significantly and reproducibly the response to peptide 51-66. An explanation for this synergy is that these peptides may be further processed (28) and, as a result, both may fit into a single MHC binding site or they may form crossreactive epitopes upon binding to MHC molecules. The possibility of further processing is supported by our observation that the two peptides compete, instead of synergizing, when tested on fixed APC incapable of processing . However, the alternative possibility that these two peptides influence each other in solution before binding to the presenting molecules, also remains open .
The degree of "foreigness" to the mouse immune system does not exert a major influence in determining immunodominance since, for example, the immunodominant HEL sequence 51-61 has only one amino acid substitution as compared with the corresponding mouse sequence (29) , whereas the nonimmunodominant peptide 25-43 has seven.
It has been suggested that amphipathicity is an important feature of immunodominant T cell epitopes (30) , but other studies (31) argue that the helix formed need not be amphipathic. Among the immunodominant T cell epitopes we have studied, the sequences 51-61 and 1-18 exhibit amphipathicity but 112-129 does not, indicating that this property is not essential for immunodominance .
The immunodominance of a given T cell epitope may also depend on its capacity to induce preferentially helper or suppressor T cells. Although this mechanism has not been addressed in the present work, it appears to operate, under certain conditions, in the anti-HEL immune response (32) .
In conclusion, the phenomenon of epitope dominance appears to be the outcome of a complex interplay between physical-chemical rules governing peptide-MHC interactions and a series of biological mechanisms. The present work has demonstrated four distinct mechanisms operating in the determination of dominant epitopes, but leaves the possibility that further ones exist open.
Summary
The preferential recognition of certain amino acid sequences from foreign protein antigens by T cells is referred to as T cell epitope immunodominance. To determine the mechanisms underlying this phenomenon, we have studied the correlation between the interaction of a series of synthetic peptides encompassing the entire hen egg-white lysozyme (HEL) sequence. with class II molecules of the H-2k haplotype, and T cell responsiveness to these peptides . After HEL priming, three immunodominant T cell epitopes were found: two, included in the HEL sequences 51-61 and 112-129, were recognized in association with I-A' molecules, and one, included in sequence 1-18, in association with I-E' molecules . Accordingly, these peptides bound to the appropriate class II molecule, as demonstrated by competition for antigen presentation . Several other HEL peptides, although capable of associating with class 11 molecules, were not immunodominant . The absence of immunodominance has been shown to arise by three different mechanisms: (a) competition by an immunodominant peptide for presentation in vivo, (b) failure to generate the peptide during antigen processing, and (c) an inherently poor capacity of the T cell repertoire to respond to a particular peptide-MHC complex.
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